EQB slumps after Q3 profit misses estimates
ReutersAug 28, 2025 5:57 PM
** Shares of Canadian bank EQB EQB.TO fall 13% to C$88.45 in early trading
** After markets closed on Wednesday, EQB reported Q3 profit that missed analysts' estimates
** Co reported adjusted profit of C$2.07 per share for the three months ended July 31, missing analysts' average estimate of C$2.60 per share - data compiled by LSEG
** Net interest income fell to C$250 mln from C$271.4 mln in the year-ago period
** Including session moves, EQB down ~10.6% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
NVIDIA Q2 FY2026: Surfing the AI Surge with Blackwell, Steering Through China’s Export Challenges
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) reported strong Q2 FY2026 results on August 27, 2025, after market close, driven by robust AI-powered demand and adoption of its next-generation Blackwell GPU platform. The company delivered significant revenue and profit beats overall, with...TradingKey
20 hours ago
U.S. Dollar Index: Assessing Its Future Trend Through Macro Analysis of the U.S., Eurozone, Japan, and U.K.
TradingKey - Looking ahead, in the U.S., slowing economic growth combined with ongoing interest rate cuts will exert downward pressure on the dollar. In the Eurozone, weak economic performance and continued ECB rate cuts will likely depreciate the euro, indirectly supporting the U.S. Dollar Index...TradingKey
Mon, Aug 25
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.TradingKey
Thu, Aug 7
CrowdStrike Stock Falls 9% After Disappointing Guidance: Time to Buy the Dip?
TradingKey - Cybersecurity is a booming industry, but even the best stocks can hit speed bumps. That’s exactly what happened to CrowdStrike Holdings Inc (NASDAQ: CRWD) after the company released its latest earnings report.TradingKey
Wed, Mar 5
